# Kiora Pharmaceuticals Inc: Form 8-K, filed Jun 21, 2023

- Company: [Kiora Pharmaceuticals Inc](/companies/kprx.md) (CIK 1372514)
- Form: 8-K
- Filed: 2023-06-21
- Accepted by EDGAR: Jun 21, 2023, 16:25 ET
- Period: 2023-06-21
- Accession: 0001372514-23-000103
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1372514/000137251423000103/kprx-20230621.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1372514/000137251423000103/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1372514/000137251423000103/kprx-20230621.htm

Filed Jun 21, 2023.
Source: SEC EDGAR, the filing index for accession 0001372514-23-000103. Last ingested by Listed: Nov 12, 2026, 17:43 ET. No prices; not investment advice.
